Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
21.87
+1.64 (8.11%)
Sep 15, 2025, 3:45 PM EDT - Market open
Zenas BioPharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$32.29
Upside
+47.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +37.17% | May 16, 2025 |
| Wedbush | Wedbush | Buy Initiates $35 | Buy | Initiates | $35 | +60.04% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +105.76% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +37.17% | Mar 12, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $19 | Buy | Initiates | $19 | -13.12% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +37.17% | Dec 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +60.04% | Dec 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 3, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +23.46% | Oct 8, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +60.04% | Oct 8, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +82.90% | Oct 8, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +105.76% | Oct 8, 2024 |